Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2519 (LINC02519) is a member of the long non-coding RNA (lncRNA) family, specifically classified as a long intergenic non-coding RNA (lincRNA)[5]. LincRNAs are transcripts longer than 200 nucleotides that do not overlap with protein-coding genes[1]. They have essential roles in regulation of gene expression, chromatin remodeling, recruitment of protein complexes, modulation of nuclear architecture, and can act as scaffolds for protein and RNA interactions[1][3][7]. While some lincRNAs have been directly linked to diseases such as cancer or genetic disorders, publicly available databases do not currently report a specific functional or disease-related role for LINC02519[5]. There are no known drug interactions, biomarker uses, or safety concerns associated with this RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2519 (LINC02519).